Fast MRI Compared to Routine Clinical MRI in Children With Brain Tumor
Study Details
Study Description
Brief Summary
This study aims to assess the diagnostic performance of a new fast MRI sequence named Neuromix compared to routine clinical MRI for brain tumor in pediatric patients
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The study aims to assess the diagnostic performance of fast MR sequence for the radiological evaluation of brain tumor in comparison to routine clinical MRI in a pediatric population. The primary outcome is the depiction and characterization of brain tumor pathology. Sensitivity, specificity, AUC and intra-/ interreader agreement for the diagnostic performance of Neuromix compared to cMRI will be obtained.
Secondary outcomes will also include the assessment of diagnostic image quality and image artifacts.
The study population will consist of subjects aged 0-18 with a suspected or diagnosed brain tumor referred for routine MRI examination of the brain.
Study subjects will be investigated during the same day at 3T MR with Neuromix sequence in addition to the routine MRI examination.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Pediatric patients with suspected or confirmed brain tumor New method och standard MRI in clinical care |
Diagnostic Test: Fast MRI (Neuromix)
Diagnostic performance, correlation, agreement
|
Outcome Measures
Primary Outcome Measures
- Diagnostic performance [Through study completion, an average of 1 year]
AUC, area under the curve for the comparison of the new method against the reference standard
Secondary Outcome Measures
- Imaging artifacts [through study completion, an average of 1 year]
Image artifacts on both methods
- Imaging quality [through study completion, an average of 1 year]
Image quality on both methods
- Correlation [through study completion, an average of 1 year]
Correlation between readers and methods
- Agreement [through study completion, an average of 1 year]
Agreement between readers and methods
- Sensitivity [through study completion, an average of 1 year]
Sensitivity of the new method against the reference standard
- Specificity [through study completion, an average of 1 year]
Specificity of the new method against the reference standard
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 0-18 years.
-
Pediatric subjects with diagnosed brain tumor
-
Referral routine MRI study.
Exclusion Criteria:
-
MRI planned without sedation
-
Aborted MR exam
-
Unstable patient
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Karolinska University Hospital
Investigators
- Principal Investigator: Anna Falk Delgado, Ass Prof, Karolinska Institutet
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ALF Project 520205